glp 1 agonists oral FDA just approved orforglipron (Foundayo), Eli Lilly's GLP-1 receptor agonist for obesity. In the ATTAIN-1 phase 3 trial (n=3,127), published in the New England Journal of Medicine, patients on the highest How Does Orforglipron Advance Oral

What form of vitamin B-12 appeared best at raising B-12 levels among people on plant-based diets in a new study, and how did this compare to getting B-12 from plant-based foods

These metabolites are critical regulators of redox homeostasis, energy balance, and amino acid metabolismkey processes that are frequently disrupted in chronic metabolic diseases

It's a sunless tan summer, thanks to the widespread chatter about the synthetic peptide melanotan II

GLP-1 drugs have unexpectedly been found to potentially help with addiction disorders such as those associated with nicotine and other substances (Manalac, Dec 2024)

LC is reported to have benefits in the management of infertility [5, 6]

Unapproved drugs sold at a Pennsylvania supplement store